weight regain after stopping glp-1 medications Trajectory of cessation of receptor agonists: a systematic review and nonlinear meta-regression Phentermine vs GLP-1: how the

Another oral drug for alopecia, called baricitinib, was approved by the FDA in 2022 to exclusively treat adults

JCO Oncology Practice, 2026

Addressing Skin Elasticity During Rapid Weight Loss Loose skin following major weight loss represents one of the most significant concerns affecting quality of life outcomes

Bimagrumab addresses a critical unmet need. Mark Pruzanski The advantage: While people on GLP-1 agonists tend to gain back any weight lost if they stop taking the meds, that might not be the case for bimagrumab 12 weeks after their last dose, the people in the 1,000-person phase 2 trial had yet to regain any weight

Studies show that GLP-1 acts on the intestinal wall to slow stomach emptying, activating nerves that slow muscle contractions that would normally push food along

TAPI, a peptide-focused CDMO, has described deploying UV and RI monitoring alongside in-line mass spectrometry-based sequence verification to create a data-rich manufacturing environment that replaces retrospective batch testing with continuous in-process quality assurance